Cal INDEX, Inland Empire merge to form largest HIE in California

The California Integrated Data Exchange (Cal INDEX) and Inland Empire Health Information Exchange (IEHIE) announced plans to merge, forming the largest nonprofit health information exchange (HIE) in California.

The combination of Cal INDEX's 11.7 million claims records with the five million clinical patient records with IEHIE's 150 partners will be led by former White House technology senior advisor Claudia Williams. With over 25 years of experience in healthcare technology, Williams background makes her the top pick for CEO of this merger.

"The creation of this new statewide health information exchange by IEHIE and Cal INDEX is an important milestone in transforming California's healthcare system into a coordinated system that delivers higher quality and more efficient care to all Californians," said Bradley Gilbert, MD, MPP, chairman of the IEHIE board. 

Mark Savage, chairman of the Cal INDEX board, added: "Claudia is the ideal candidate to lead this new entity. She is a strategic and transformational leader with national experience managing and scaling health information exchanges. With Claudia, California's statewide HIE gets the rare combination of breadth and depth."

HIE provides the ability to review and analyze complete lists of patient data makes for more effective care for the people pf California.

"I'm thrilled by the opportunity to lead the new organization and collaborate with our partners to improve patient care for all Californians," said Williams. "Our goal is to deliver compelling products and services that support California's hospitals, providers and patients in their efforts to improve care coordination, reduce inefficiencies, address gaps in care and enhance patient experience."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup